3D Global Biotech (6808 TT, Market Cap USD160m) is a pioneering Taiwanese small-cap firm at the forefront of 3D bioprinting and regenerative medicine, specializing in customized tissue and organ reconstruction.

Originating from Taipei Medical University, the company has established a strong competitive advantage through proprietary bio-inks, advanced 3D cell culture, and a proven track record of securing critical international regulatory approvals, including US FDA 510(K) and Thai FDA clearances.

Its business model focuses on personalized medical devices, supported by strategic partnerships like the one with Japan's WHITE LIGN Inc., positioning it uniquely within the rapidly expanding global markets for 3D bioprinting and regenerative therapies.

Financially, 3D Global Biotech demonstrated a remarkable turnaround in 2024, achieving an extraordinary 1,187.68% increase in revenue to NT$265.69 million, marking a pivotal shift from consistent losses to a net profit of NT$91.701 million.

This impressive performance was largely driven by the successful commercialization of its orthodontic aligners and the strategic leverage of its partnerships, indicating growing market acceptance and operational efficiency.

Despite its strong position and recent successes, 3D Global Biotech faces inherent risks common to the biotechnology sector, including stringent and evolving regulatory frameworks, the costly and uncertain nature of clinical trials, intense competition, and the capital-intensive demands of ongoing R&D.

Investors should consider 3D Global Biotech as a high-growth opportunity within the burgeoning regenerative medicine landscape, but one that requires a long-term investment horizon given these pervasive industry challenges. Continued innovation, successful scaling of commercial efforts, and strategic partnerships will be crucial for sustaining its growth and market leadership.

DECK

3d Global Biotech (6808 Tt) Slides

456KB ∙ PDF file

Download

Download

Most investors optimize for safety.
We optimize for upside.

What We Believe

• Great investments aren’t found in backtests. They’re earned through conviction.

• There’s no such thing as a “safe” stock — just misunderstood ones.

• Wealth is not created through caution. It’s created through courage, and held through pain.

• Most investors hedge. We hold. And we wait.

What You’ll Get

Each week, you’ll receive one high-conviction multibagger idea — or a follow-up on a previous pick.
No fluff. No filler. Often in the form of a short slide deck or teardown.

We use AI to gather, transcribe, and surface signal. But the decisions, the conviction, and the edge — that’s still human.

Year 1 is free. After that, we’ll raise prices annually — because the signal is only getting stronger.

Why This Exists

We started Multibaggers Club because we were tired of noise.
Tired of 2% alpha. Tired of market commentary dressed up as insight.
Tired of playing defense.

This is for people who want more — who are willing to think independently, commit deeply, and ride the rough edges of real wealth creation.

If that sounds like you, welcome. You’re one of us.

The first Idea Drop lands soon.

Until then —
Stay sharp.
Stay convicted.

— The Multibagger Desk